Key result
In two cases of primary cardiac lymphoma, one patient achieved complete response at 24 months with R-HDS chemotherapy and stem cell transplant, while the other died 2 weeks after presentation.
Case Report (n=2)
Primary cardiac lymphoma is a rare condition with variable prognosis, where aggressive chemotherapy and stem cell transplantation may yield complete response in select patients.
No takes yet. Share an insight, caveat, or question.
Supports hypothesis of benefit from intensive therapy in select cases; leaves open need for prospective trials in primary cardiac lymphoma.
Anghel et al. (2003) conducted a case report in Primary cardiac lymphoma (n=2). Chemotherapy (R-HDS with stem cell transplantation or cyclophosphamide/vincristine) was evaluated on Clinical outcome (survival and disease response). In two cases of primary cardiac lymphoma, one patient achieved complete response at 24 months with R-HDS chemotherapy and stem cell transplant, while the other died 2 weeks after presentation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: